FDA Approved: FLUCONAZOLE — Supplemental Application (Hospira, Inc)

View source ↗

Summary

The FDA approved a supplemental application for fluconazole submitted by Hospira, Inc., authorizing changes to the product under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Cryptococcal Meningitis
• Disseminated Candidiasis
• Esophageal Candidiasis
• Oropharyngeal Candidiasis
• Vulvovaginal Candidiasis

Drugs mentioned

• Fluconazole (Hospira) (Fluconazole)

Snippet

SUPPL AP for FLUCONAZOLE (FLUCONAZOLE)